H
Hirotsugu Oda
Researcher at National Institutes of Health
Publications - 7
Citations - 698
Hirotsugu Oda is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Enhancer & Chromatin remodeling. The author has an hindex of 4, co-authored 7 publications receiving 261 citations.
Papers
More filters
Journal ArticleDOI
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
David B. Beck,Marcela A. Ferrada,Keith A. Sikora,Amanda K. Ombrello,Jason C. Collins,Wuhong Pei,Nicholas Balanda,Daron L. Ross,Daniela Ospina Cardona,Zhijie Wu,Bhavisha A Patel,Kalpana Manthiram,Emma M. Groarke,Fernanda Gutierrez-Rodrigues,Patrycja Hoffmann,Sofia Rosenzweig,Shuichiro Nakabo,Laura W. Dillon,Christopher S. Hourigan,Wanxia L. Tsai,Sarthak Gupta,Carmelo Carmona-Rivera,Anthony J. Asmar,Lisha Xu,Hirotsugu Oda,Wendy Goodspeed,Karyl S. Barron,Michele Nehrebecky,Anne Jones,Ryan S. Laird,Natalie Deuitch,Dorota Rowczenio,Emily Rominger,Kristina V. Wells,Chyi-Chia Richard Lee,Weixin Wang,Megan Trick,James C. Mullikin,Gustaf Wigerblad,Stephen R. Brooks,Stefania Dell'Orso,Zuoming Deng,Jae Jin Chae,Alina Dulau-Florea,May Christine V. Malicdan,Danica Novacic,Robert A. Colbert,Mariana J. Kaplan,Massimo Gadina,Sinisa Savic,Helen J. Lachmann,Mones Abu-Asab,Benjamin D. Solomon,Kyle Retterer,William A. Gahl,Shawn M. Burgess,Ivona Aksentijevich,Neal S. Young,Katherine R. Calvo,Achim Werner,Daniel L. Kastner,Peter C. Grayson +61 more
TL;DR: Using a genotype-driven approach, this disorder is identified that connects seemingly unrelated adult-onset inflammatory syndromes and is named the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.
Journal ArticleDOI
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease
Najoua Lalaoui,Najoua Lalaoui,Steven E. Boyden,Hirotsugu Oda,Geryl Wood,Deborah L. Stone,Diep Chau,Lin Liu,Lin Liu,Monique Stoffels,Tobias Kratina,Kate E. Lawlor,Kate E. Lawlor,Kristien J. M. Zaal,Patrycja Hoffmann,Nima Etemadi,Nima Etemadi,Kristy Shield-Artin,Kristy Shield-Artin,Christine Biben,Christine Biben,Wanxia Li Tsai,Mary Blake,Hye Sun Kuehn,Dan Yang,Holly Anderton,Holly Anderton,Natasha Silke,Laurens Wachsmuth,Lixin Zheng,Natalia Sampaio Moura,David B. Beck,Gustavo Gutierrez-Cruz,Amanda K. Ombrello,Gineth Pinto-Patarroyo,Andrew J. Kueh,Andrew J. Kueh,Marco J Herold,Marco J Herold,Cathrine Hall,Hongying Wang,Jae Jin Chae,Natalia I. Dmitrieva,Mark D. McKenzie,Mark D. McKenzie,Amanda Light,Beverly K. Barham,Anne Jones,Tina Romeo,Qing Zhou,Ivona Aksentijevich,James C. Mullikin,Andrew J. Gross,Anthony K. Shum,Edwin D. Hawkins,Edwin D. Hawkins,Seth L. Masters,Seth L. Masters,Michael J. Lenardo,Manfred Boehm,Sergio D. Rosenzweig,Manolis Pasparakis,Anne K. Voss,Anne K. Voss,Massimo Gadina,Daniel L. Kastner,John Silke,John Silke +67 more
TL;DR: It is shown that caspase cleavage of RIPK1 not only inhibits necroptosis but also maintains inflammatory homeostasis throughout life, and a cleavage-resistant Ripk1 D325A mutant mouse strain generated limits TNF-induced cell death and inflammation.
Journal ArticleDOI
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC.
Hirotsugu Oda,David B. Beck,Hye Sun Kuehn,Natalia Sampaio Moura,Patrycja Hoffmann,Maria Ibarra,Jennifer Stoddard,Wanxia Li Tsai,Gustavo Gutierrez-Cruz,Massimo Gadina,Sergio D. Rosenzweig,Daniel L. Kastner,Luigi D. Notarangelo,Ivona Aksentijevich +13 more
TL;DR: The second case of HOIP deficiency with novel compound heterozygous mutations in RNF31 and distinct clinical and molecular features is reported, expanding on the clinical spectrum ofHOIP deficiency and molecular signatures associated with LUBAC deficiency.
Journal ArticleDOI
Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.
Hirotsugu Oda,Daniel L. Kastner +1 more
TL;DR: This review covers several of the prominent recent advances in the field of autoinflammatory diseases, including gene discoveries, the elucidation of new pathogenic mechanisms, and the development of effective targeted therapies.
Journal ArticleDOI
Linkage-specific deubiquitylation by OTUD5 defines an embryonic pathway intolerant to genomic variation.
David B. Beck,Mohammed Abul Basar,Anthony J. Asmar,Joyce J. Thompson,Hirotsugu Oda,Daniela Tiaki Uehara,Ken Saida,Sander Pajusalu,Sander Pajusalu,Sander Pajusalu,Inga Talvik,Precilla D'Souza,Joann Bodurtha,Weiyi Mu,Kristin W. Barañano,Noriko Miyake,Raymond Y. Wang,Marlies Kempers,Tomoko Tamada,Yutaka Nishimura,Satoshi Okada,Tomoki Kosho,Ryan K. Dale,Apratim Mitra,Ellen Macnamara,Naomichi Matsumoto,Johji Inazawa,Magdalena Walkiewicz,Katrin Õunap,Katrin Õunap,Cynthia J. Tifft,Ivona Aksentijevich,Daniel L. Kastner,Pedro P. Rocha,Achim Werner +34 more
TL;DR: The LINKED (LINKage-specific deubiquitylation deficiency-induced Embryonic Defects) syndrome was identified in this paper, which is caused by hemizygous variants in OTUD5.